Eating Plan – Bootea. We have never and will never tell you that Bootea alone is a magic formula to meet your weight loss goals. As with anything, balance is key and we have therefore created a flexible eating plan which helps to optimise the weight loss process and get you on your way to a healthier you. We provide various healthy options for breakfast, lunch, dinner and two snacks. We do NOT advocate an . If you're following this plan and you find yourself still hungry we recommend adding in another snack or two from our healthy options list to keep you going. This will download the PDF file to your computer). If I do not follow the eating plan will I still achieve good results? Yes. We know everyone is different so we don’t want to force you to eat something you don’t like. You will achieve results if you create your own eating plan. In. Play from Briefing. Golub Capital prices public offering of 1. GBDC) : The Company intends to use the net proceeds from the offering to invest in portfolio companies in accordance with its investment objective and strategies and for general corporate purposes. Rexahn Pharmaceuticals to sell approx. RNN) : The shares and warrants are being sold in units, each consisting of one share of common stock and a warrant to purchase 0. Shot. Spotter (Nasdaq) prices 2. IPO at $1. 1. 0. 0, the midpoint of the expected $1. SSTI) : 8: 5. 0 am S& P futures vs fair value: +2. Nasdaq futures vs fair value: +1. Australia's first quarter GDP beat expectations, but increased just 1. The People's Bank of China raised the yuan fix for the sixth consecutive day, lifting the currency to its strongest level since early November. Elsewhere, the Reserve Bank of India left its key interest rate at 6. Major European indices trade mostly higher while the UK's FTSE (- 0. The euro has retreated 0. Bloomberg report, which claimed the European Central Bank will lower its inflation outlook through 2. The ECB will release its latest policy statement tomorrow at 7: 4. ET. 8: 4. 6 am National Commerce prices public offering of 9. Company's common stock at a price to the public of $3. NCOM) : 8: 3. 7 am Linn Energy to exit California with Brea asset sale of $1. LNGG) : 8: 3. 2 am Allergan acquires Keller Medical, a privately held medical device company and developer of the Keller Funnel (AGN) : The Keller Funnel is a cone- shaped, lubricated plastic funnel that reduces surgeon and patient contact during breast augmentation or reconstruction procedures. United Continental reports May 2. RPMs +2. 6% Y/Y, ASMs +3. Y/Y, load factor of 8. Y/Y, co continues to expect 2. Q1. 7 consolidated passenger unit revenue to be up 1- 3% Y/Y despite warning about Pacific region weakness (UAL) : Co states, . We will continue to build on this momentum as we head into the busy summer travel season.. The company continues to expect second- quarter 2. However, the Pacific region is experiencing incremental weakness due to unfavorable supply and demand dynamics in China and Hong Kong. This work is supported by grants to Sanaria from NIAID, NIH and U. S. Dept of Defense. Cryoport's expertise in cryogenic logistics will be applied to distribution models for Sanaria Pf. SPZ Vaccine for travel clinics (NIAID, NIH grant) and the U. S. This work will assist in the implementation of Phase 3 clinical trials of the vaccine and the development of cryogenic logistics distribution in support of the anticipated commercial launch of Pf. SPZ Vaccine, which is cryopreserved. Cerus announces that the expected Fresenius Kabi platelet additive solution shortage the company announced on May 2. INTERCEPT platelets than initially anticipated (CERS) : This follows a decision by the FDA to review a recent submission by Fresenius Kabi as a Changes Being Effected in 3. Days (CBE- 3. 0) supplement, which allows ongoing distribution of the product during the review period. The CBE- 3. 0 was necessary to address some changes in raw materials used by the manufacturer of the PAS container. Greenman continued. Upland Software prices public offering of approximately 1. Keenwell - We believe consumers should be aware that Keenwell appears to be more concerned with cosmetic approaches to skincare. The ingredients used in our teas have been used for centuries for health and wellbeing purposes but it is only now we have finally brought all these unique. Free trials are NOT free. Read our investigative report on how free trials really work, and how to avoid being scammed when you purchase wrinkle creams online. 4:30 pm Closing Market Summary: Stock Market Closes at Record High (:WRAPX): The major U.S.UPLD) : 8: 2. 9 am S& P futures vs fair value: +2. Nasdaq futures vs fair value: +1. The S& P 5. 00 futures currently trade three points, or 0. Recent polls suggest that Prime Minister Theresa May's Conservative Party has just a six- point advantage over the Labour Party, which is considerably lower than the 1. April. Meanwhile, the euro (1. U. S. Comey may stop short of suggesting President Trump obstructed justice when he testifies before the Senate Intelligence Committee tomorrow. As a reminder, the New York Times reported last month that Mr. Trump asked Mr. Comey to shut down the FBI's investigation of former National Security Advisor Michael Flynn. If true, the incident may qualify as an obstruction of justice, which is considered an impeachable offense. Bayer AG places 8. Covestro's shares and EUR 1 billion bonds exchangeable into Covestro shares (BAYRY) : Co has reduced its direct holding in Covestro from 5. This was achieved by selling 1. Covestro shares at a price of EUR 6. The planned deposit in Bayer Pension Trust e. Covestro will continue to be fully consolidated in Bayer's financial statements since Bayer should continue to hold the majority at a Covestro annual stockholders meeting after these transactions are completed.
We have never and will never tell you that Bootea alone is a magic formula to meet your weight loss goals. As with anything, balance is key and we have therefor. As previously announced, Bayer aims to achieve full separation from Covestro in the medium term. Gapping down (SCANX) : Gapping down. In reaction to disappointing earnings/guidance: DLTH - 1. ALOG - 9. 5%, SIGM - 7. NAV - 7%, AMBA - 4. July 1, 2. 01. 7), OXM - 2. PLAY - 2. 5%, (also adds $1. UNFI - 2. 2%, USPH - 1. Other news: KMDA - 7. Shire (SHPG) of the Investigational New Drug application approved by the FDA for the Phase 2/3 study evaluating Alpha- 1 Antitrypsin)EXAS - 4. GBDC - 2. 1% (announces public offering of 1. SHPG - 1. 7% (KMDA to assume ownership from Shire of the Investigational New Drug application approved by the FDA for the Phase 2/3 study evaluating Alpha- 1 Antitrypsin)VLRS - 1. May traffic)UPLD - 1. AZN - 1. 1% (to divest rights to Zomig outside of Japan for $2. Analyst comments: QHC - 2. Underweight at Morgan Stanley)RCII - 2. Sell from Hold at Loop Capital)IRM - 2. Sell from Hold at Deutsche Bank)IMAX - 1. Hold from Buy at The Benchmark Company)KO - 0. Market Perform from Outperform at BMO Capital)PEP - 0. Market Perform from Outperform at BMO Capital)CYH - 0. Underweight at Morgan Stanley)8: 1. Gapping up (SCANX) : Gapping up In reaction to strong earnings/guidance: CVNA +8. SEAC +7%, KEYS +6%, HOME +1. M& A news: SAN +1. Banco Popular Espanol SA)Other news: DRWI +5. Smart. Sky Networks, a North American 4. G LTE inflight service provider)NNVC +3. VZV in multiple cell culture studies)WINS +7. NVAX +4. 9% (announces that data from the second of two Phase 2 trials of its RSV F protein recombinant nanoparticle vaccine candidate)CTIC +4. DVAX +4. 3% (Point. Asset Management increases passive stake )PLX +4. II trial results for alidornase alfa (PRX- 1. Cystic Fibrosis)AMD +3. GRAM +3. 4% (sells stake in GMD)EGLT +3. Ascend Therapeutics to co- promote SPRIX Nasal Spray to more than 9,0. HA +2. 2% (reports May 2. RPMs +8%, ASMs +5% and load factor +2. Q2 Operating Revenue Per ASM +7. DXCM +1. 2% (announces FDA approval of the Dexcom G5 mobile app for Android devices)HOLX +1. FDA has approved co's Genius 3. D Mammography exam), . Analyst comments: CTSO +3. Outperform at Cowen; tgt $7)RBS +2. Hold from Sell at Investec)ORA +1. Overweight from Neutral at JP Morgan)LPNT +0. Outperform from Mkt Perform at Leerink Partners)DPS +0. Outperform from Market Perform at BMO Capital)8: 1. Magnegas regains compliance w/ the minimum bid price requirement for continued listing on the NASDAQ (MNGA) : 8: 1. Delphi Automotive and Transdev announce a commercial partnership to develop a global, fully automated, mobility- on- demand transport system (DLPH) : The system will utilize Transdev Universal Routing Engine (URE) and Delphi's previously announced automated driving platform - - the Centralized Sensing, Planning and Localization (: CSLP) platform which Delphi is developing in partnership with Mobileye. Teva Pharma announces that the second Phase III HALO study of fremanezumab met all primary and secondoary endpoints; co plans to submit a BLA to the FDA for fremanezumab later this year in both episodic and chronic migraine w/ anticipated approval and launch in 2. H1. 8 (TEVA) : In the episodic migraine (: EM) study, patients treated with monthly and quarterly fremanezumab experienced clinically and statistically significant improvements in all endpoints and 1. Participants in this trial had a mean of 9. Fremanezumab given monthly improved the average number of migraine days, relative to baseline, by 4. Number of days with disability were decreased by 6. The quarterly SC dose, which was uniquely tested in this program, also yielded highly significant results for decrease in migraine days (- 3. Also unique to this development, both dose regimens highly significantly improved migraine in subjects on stable doses of other prophylactic medications (- 4. All other pre- specified analyses were met and were highly statistically significant. The most commonly- reported adverse event in the study was injection site pain, with similar rates in the placebo and active groups. Inovio Pharma announces its Zika vaccine (GLS- 5. Zika virus- induced damage to testes and sperm, and prevented persistence of the virus in the reproductive tract of all vaccinated male mice challenged with a high dose of the Zika virus' (INO) : This preclinical study data was published in Nature Communications in an article entitled, . Moreover, two doses or a single dose of vaccine generated a robust antibody response in 9. Inovio's second phase I study of 1. Puerto Rico (ZIKA- 0. In this randomized, placebo- controlled, double- blind trial, 8. The study is evaluating the safety, tolerability and immunogenicity of GLS- 5. Zika infection rates between the arms as an exploratory signal of vaccine efficacy. RMR Group confidentially submits draft registration statement related to a proposed IPO of common shares for a newly formed commercial mortgage REIT which would be managed by an SEC registered investment advisor subsidiary of RMR (RMR) : 8: 0. STRATA Skin Sciences announces holders to exchange approx. Novavax publishes data in Vaccine from the second of two Phase 2 trials of its RSV F protein recombinant nanoparticle vaccine candidate in women of child bearing age; trial demonstrated a reduction of rsv infection in vaccinated women of greater than 5. NVAX) : . Together, these data suggest that the RSV F Vaccine provided protection against RSV infection in controlled trials of over 1,0.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
October 2017
Categories |